{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:20:46Z","timestamp":1707524446696},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,10]]},"DOI":"10.7759\/cureus.43307","type":"journal-article","created":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T02:20:21Z","timestamp":1691720421000},"source":"Crossref","is-referenced-by-count":0,"title":["Minocycline-Induced Ocular Ochronosis"],"prefix":"10.7759","author":[{"given":"Carla","family":"Baaklini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha","family":"Kesav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Reinhart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Minocycline (systemic): drug information","year":"2023","unstructured":"Minocycline (systemic). drug information. UpToDate. Post TW (ed): UpToDate, Waltham; 2023."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1159\/000526067","article-title":"Blue skin, nail, and scleral pigmentation associated with minocycline","volume":"14","author":"Ricardo JW","year":"2022","unstructured":"Ricardo JW, Shah K, Minkis K, Lipner SR. Blue skin, nail, and scleral pigmentation associated with minocycline. Case Rep Dermatol. 2022, 14:239-42. 10.1159\/000526067","journal-title":"Case Rep Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-245508","article-title":"Minocycline-induced blue sclera and skin hyperpigmentation","volume":"14","author":"Law S","year":"2021","unstructured":"Law S. Minocycline-induced blue sclera and skin hyperpigmentation. BMJ Case Rep. 2021, 14:10.1136\/bcr-2021-245508","journal-title":"BMJ Case Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajoc.2022.101386","article-title":"Minocycline-induced scleral pigmentation","volume":"26","author":"Al Hussein Al Awamlh S","year":"2022","unstructured":"Al Hussein Al Awamlh S, Taubenslag KJ, Gangaputra S. Minocycline-induced scleral pigmentation. Am J Ophthalmol Case Rep. 2022, 26:101386. 10.1016\/j.ajoc.2022.101386","journal-title":"Am J Ophthalmol Case Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/s0161-6420(97)30204-8","article-title":"Minocycline-induced scleral pigmentation","volume":"104","author":"Fraunfelder FT","year":"1997","unstructured":"Fraunfelder FT, Randall JA. Minocycline-induced scleral pigmentation. Ophthalmology. 1997, 104:936-8. 10.1016\/s0161-6420(97)30204-8","journal-title":"Ophthalmology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2018.3088","article-title":"Long-term minocycline therapy with scleral pigmentation simulating melanocytosis","volume":"136","author":"Maloney SM","year":"2018","unstructured":"Maloney SM, Williams BK Jr, Shields CL. Long-term minocycline therapy with scleral pigmentation simulating melanocytosis. JAMA Ophthalmol. 2018, 136:e183088. 10.1001\/jamaophthalmol.2018.3088","journal-title":"JAMA Ophthalmol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2017.5148","article-title":"Progressive bilateral scleral pigmentation in a patient with ocular hypertension","volume":"136","author":"Rojas R","year":"2018","unstructured":"Rojas R, Hassan OM, Vajaranant TS. Progressive bilateral scleral pigmentation in a patient with ocular hypertension. JAMA Ophthalmol. 2018, 136:587-8. 10.1001\/jamaophthalmol.2017.5148","journal-title":"JAMA Ophthalmol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.16176","article-title":"Blue pigmentation of the skin, sclera, and teeth","volume":"326","author":"Ran NA","year":"2021","unstructured":"Ran NA, Hedberg ML, Rosenbach M. Blue pigmentation of the skin, sclera, and teeth. JAMA. 2021, 326:1851-2. 10.1001\/jama.2021.16176","journal-title":"JAMA"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199818060-00004","article-title":"Minocycline-induced pigmentation. Incidence, prevention and management","volume":"18","author":"Eisen D","year":"1998","unstructured":"Eisen D, Hakim MD. Minocycline-induced pigmentation. Incidence, prevention and management. Drug Saf. 1998, 18:431-40. 10.2165\/00002018-199818060-00004","journal-title":"Drug Saf"},{"key":"ref10","article-title":"Bilateral tarsal conjunctival pigmentation after eight months of minocycline therapy","volume":"73","author":"Kudrna JJ","year":"2020","unstructured":"Kudrna JJ, Eisenbeisz HC, Huot C. Bilateral tarsal conjunctival pigmentation after eight months of minocycline therapy. S D Med. 2020, 73:360-5.","journal-title":"S D Med"},{"key":"ref11","doi-asserted-by":"crossref","DOI":"10.3129\/i07-084","article-title":"Scleral and conjunctival pigmentation following minocycline therapy","volume":"42","author":"McAllum P","year":"2007","unstructured":"McAllum P, Slomovic A. Scleral and conjunctival pigmentation following minocycline therapy. Can J Ophthalmol. 2007, 42:626-7.","journal-title":"Can J Ophthalmol"},{"key":"ref12","article-title":"A brown-eyed woman with blue discoloration of the sclera. Minocycline-induced hyperpigmentation","volume":"72","author":"Bosma JW","year":"2014","unstructured":"Bosma JW, Veenstra J. A brown-eyed woman with blue discoloration of the sclera. Minocycline-induced hyperpigmentation. Neth J Med. 2014, 72:33, 37.","journal-title":"Neth J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMicm1702031","article-title":"Scleral discoloration from minocycline treatment","volume":"378","author":"Arshad J","year":"2018","unstructured":"Arshad J, Sayegh R. Scleral discoloration from minocycline treatment. N Engl J Med. 2018, 378:1537. 10.1056\/NEJMicm1702031","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.121.1.144JAMA","article-title":"Minocycline-induced ocular pigmentation","volume":"121","author":"Bradfield YS","year":"2003","unstructured":"Bradfield YS, Robertson DM, Salomao DR, Link TP, Rostvold JA. Minocycline-induced ocular pigmentation. Arch Ophthalmol. 2003, 121:144-5. 10.1001\/archopht.121.1.144JAMA","journal-title":"Arch Ophthalmol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3928\/23258160-20160324-09","article-title":"Swept-source optical coherence tomography and OCT angiography of minocycline-induced retinal and systemic hyperpigmentation","volume":"47","author":"Jung JJ","year":"2016","unstructured":"Jung JJ, Chen MH, Sorenson AL, Rofagha S. Swept-source optical coherence tomography and OCT angiography of minocycline-induced retinal and systemic hyperpigmentation. Ophthalmic Surg Lasers Imaging Retina. 2016, 47:356-61. 10.3928\/23258160-20160324-09","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2015.2819","article-title":"Spectral-domain optical coherence tomographic imaging of pigmented retinal pigment epithelial deposits in a patient with prolonged minocycline use","volume":"133","author":"Wilson ME","year":"2015","unstructured":"Wilson ME, Sridhar J, Garg SJ, Forman AR. Spectral-domain optical coherence tomographic imaging of pigmented retinal pigment epithelial deposits in a patient with prolonged minocycline use. JAMA Ophthalmol. 2015, 133:1360-2. 10.1001\/jamaophthalmol.2015.2819","journal-title":"JAMA Ophthalmol"},{"key":"ref17","article-title":"Skeletal dysplasias: specific disorders","author":"Bacino B","year":"2023","unstructured":"Bacino B. Skeletal dysplasias: specific disorders. UpToDate. Post TW (ed): UpToDate, Waltham; 2023."},{"key":"ref18","article-title":"Genetics, clinical features, and diagnosis of Marfan syndrome and related disorders","author":"Wright MJ","year":"2023","unstructured":"Wright MJ, Connolly HM. Genetics, clinical features, and diagnosis of Marfan syndrome and related disorders. UpToDate. Post TW (ed): UpToDate, Waltham; 2023."},{"key":"ref19","article-title":"The Wills Eye Manual: Office and Emergency Room Diagnosis and Treatment of Eye Disease","year":"2016","unstructured":"The Wills Eye Manual. Office and Emergency Room Diagnosis and Treatment of Eye Disease. Bagheri N, Wajda B, Calvo C, Durrani A (ed): Lippincott Williams and Wilkins, Philadelphia; 2016."},{"key":"ref20","article-title":"Clinical manifestations of adrenal insufficiency in adults","author":"Nieman LK","year":"2023","unstructured":"Nieman LK. Clinical manifestations of adrenal insufficiency in adults. UpToDate. Post TW (ed): UpToDate, Waltham; 2023."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/164640-minocycline-induced-ocular-ochronosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:51:52Z","timestamp":1707508312000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/164640-minocycline-induced-ocular-ochronosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,10]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.43307","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,10]]}}}